Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study

Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications

(2015) Imayavaramban Lakshmanan et al.   Journal of Thoracic Oncology

Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma

(2014) Kyuichi Kadota et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease

(2014) Kyuichi Kadota et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

(2014) Min Hwan Kim et al.   LUNG CANCER

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

(2014) M. Macerelli et al.   LUNG CANCER

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry

(2014) Esther Conde et al.   PLoS One

Napsin A Expression in Primary Mucin-Producing Adenocarcinomas of the Lung

(2013) Jeffrey Wu et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma

(2013) Jung-Jyh Hung et al.   ANNALS OF SURGERY

Role of Napsin A and TTF1 as a Diagnostic Marker for Lung Adenocarcinoma

(2013) Jabed Iqbal   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation

(2013) Hideomi Ichinokawa et al.   HUMAN PATHOLOGY

Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome

(2013) Min Jae Cha et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis

(2013) Daquan Meng et al.   LUNG CANCER

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

(2012) Arne Warth et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)

(2012) Jacques Cadranel et al.   Journal of Thoracic Oncology

Napsin A Expression in Lung and Kidney Neoplasia

(2011) Nelson G. Ordóñez   ADVANCES IN ANATOMIC PATHOLOGY

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassay

(2010) ELSAYED I. SALIM   Oncology Letters

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

(2009) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY